UPDATE: Jefferies Initiates Coverage on Mallinckrodt on Unique Market Position

In a report published Tuesday, Jefferies analyst Anthony Petrone initiated coverage on Mallinckrodt PLC (NYSE: MNK ) with a Buy rating and $60.00 price target. In the report, Jefferies noted, “Mallinckrodt is uniquely positioned in a consolidating Specialty Pharma industry having three attractive attributes: 1) Potential long duration assets in